These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 9269906)

  • 1. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression.
    Martín R; Nieto S; Santamaría L
    Gen Diagn Pathol; 1997 Jul; 143(1):29-38. PubMed ID: 9269906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ki-67 proliferating index and histological grade, type and stage of colorectal carcinoma.
    Nabi U; Nagi AH; Sami W
    J Ayub Med Coll Abbottabad; 2008; 20(4):44-8. PubMed ID: 19999202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinico-pathological correlation and prognostic significance of nuclear p53 protein in colorectal cancer. Colorectal Cancer Study Group of the University and Health Care District of Modena.
    Fante R; Di Gregorio C; Losi L; Roncucci L; Ponz de Leon M
    Ital J Gastroenterol; 1996 May; 28(4):205-10. PubMed ID: 8842835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of p53 and c-erbB-2 immunohistochemical evaluation in colorectal adenocarcinoma.
    Lazaris AC; Theodoropoulos GE; Anastassopoulos P; Nakopoulou L; Panoussopoulos D; Papadimitriou K
    Histol Histopathol; 1995 Jul; 10(3):661-8. PubMed ID: 7579815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma.
    Zhang Hong
    Clin Cancer Res; 1999 Dec; 5(12):4126-32. PubMed ID: 10632350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma.
    Georgescu CV; Săftoiu A; Georgescu CC; Ciurea R; Ciurea T
    J Gastrointestin Liver Dis; 2007 Jun; 16(2):133-9. PubMed ID: 17592558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
    Edler D; Kressner U; Ragnhammar P; Johnston PG; Magnusson I; Glimelius B; Påhlman L; Lindmark G; Blomgren H
    Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
    Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE;
    J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases.
    Boonsong A; Curran S; McKay JA; Cassidy J; Murray GI; McLeod HL
    Hum Pathol; 2002 Nov; 33(11):1114-9. PubMed ID: 12454816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p53 and Ki-67 as prognostic factors for survival of men with colorectal cancer.
    Lumachi F; Orlando R; Marino F; Chiara GB; Basso SM
    Anticancer Res; 2012 Sep; 32(9):3965-7. PubMed ID: 22993345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
    De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
    Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 nuclear accumulation and multiploidy are adverse prognostic factors in surgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy.
    Buglioni S; D'Agnano I; Vasselli S; Perrone Donnorso R; D'Angelo C; Brenna A; Benevolo M; Cosimelli M; Zupi G; Mottolese M
    Am J Clin Pathol; 2001 Sep; 116(3):360-8. PubMed ID: 11554164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of tumor necrosis factor receptor in colorectal adenocarcinoma.
    Yoshimura H; Dhar DK; Nakamoto T; Kotoh T; Takano M; Soma G; Nagasue N
    Anticancer Res; 2003; 23(1A):85-9. PubMed ID: 12680198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low tumour cell proliferation at the invasive margin is associated with a poor prognosis in Dukes' stage B colorectal cancers.
    Palmqvist R; Sellberg P; Oberg A; Tavelin B; Rutegård JN; Stenling R
    Br J Cancer; 1999 Feb; 79(3-4):577-81. PubMed ID: 10027333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA content and its relationship with pathology and prognosis of colorectal carcinoma.
    Jiang B; Liu CG; Wang MW; Zhao DH; Li Y; Ji XL
    Chin Med J (Engl); 1992 Mar; 105(3):241-6. PubMed ID: 1395845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does p53 overexpression cause metastases in early invasive colorectal adenocarcinoma?
    Sory A; Minamoto T; Ohta T; Yamashita K; Sawaguchi K; Mai M; Misiuna P
    Eur J Surg; 1997 Sep; 163(9):685-92. PubMed ID: 9311476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis.
    Ropponen KM; Kellokoski JK; Lipponen PK; Pietiläinen T; Eskelinen MJ; Alhava EM; Kosma VM
    Br J Cancer; 1999 Sep; 81(1):133-40. PubMed ID: 10487624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
    Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
    Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of DNA ploidy pattern and nucleolar organizer regions (AgNOR) in colorectal carcinoma.
    Eminović-Behrem S; Trobonjaca Z; Petrovecki M; Dobi-Babić R; Dujmović M; Jonjić N
    Croat Med J; 2000 Jun; 41(2):154-8. PubMed ID: 10853043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.